Veracyte (VCYT) Q1 2019 Earnings Call Transcript
VCYT earnings call for the period ending March 31, 2019.
Veracyte
VCYT
VCYT
$24.52
-$0.04
0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:38 p.m.
View Interactive VCYT Charts
Veracyte Inc is engaged in the discovery development and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.
News & Analysis: Veracyte
All
Market Moves
Earnings
Veracyte Inc (VCYT) Q4 2018 Earnings Conference Call Transcript
VCYT earnings call for the period ending December 31, 2018.
Here's Why Veracyte Jumped 22.5% Higher Today
The genomic test maker posted a mighty fine third quarter.
Why First Solar, Veracyte, and KB Home Jumped Today
Stocks plunged Wednesday after Fed Chair Janet Yellen surprised the market with hints of a sooner-than-expected rate increase, but these stocks still posted strong gains. Find out more about what made these stocks soar.
Why Veracyte Inc. Shares Stormed Higher
Veracyte shares get a free pass after reporting its third-quarter earnings results.
